13F

Stock

Sarepta Therapeutics, Inc.

SRPT · held by 2 managers

Reported value

$45.6M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$9.29M

Price effect on 2 books still in the name

Largest holder

$45.6M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC398.5K$45.6M−$9.29MCut−$16.9M
Leonteq Securities AG90$10.3K−$2.1KCut−$2.1K

Who left

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.